EVEREST MED

Forecast & Rating6 analysts currently cover EVEREST MED, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$40.58, about 56.1% upside from the current price of HK$26.00. Price targets range from HK$25.77 to HK$69.56 — a wide spread, showing clear disagreement over just how much EVEREST MED can rise. Historically, about 60.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on EVEREST MED are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 5, 2026; for reference only and not investment advice.